Human growth hormone also known as somatotropin is produced by the
anterior pituitary. Growth hormone deficiency usually occurs due to
any damage to the pituitary gland and it also can be acquired
genetically. Growth hormone deficiency is common among children and
adults. Among children, it is associated with congenital conditions.
While in adults it is associated with pituitary tumors that comes
with non-specific symptoms. Various major factors driving the human
growth hormone market are research and development of long acting
drugs, the rise in the cases of HIV/AIDS and cancer, increasing
health expenditure, and increasing incidences of growth hormone
deficiency.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16283
However, the high cost of drugs, side-effects of drugs and the
off-label use of human growth hormone drugs are hampering the global
human growth hormone market. Illicit use of human growth hormone is
common among male weightlifters in America. Research by Harvard
Medical School and Brian P. Brennan of McLean Hospital found that
increasing illicit human growth hormone use may result in the new
form of drug abuse with severe health consequences. Many companies
are focusing on research and development of advanced hormonal therapy
with less adverse effects.
Leading companies in the global human growth hormone market are
GeneScience Pharmaceuticals Co., Ltd., Biopartners GmbH, Roche
Holdings, Inc., Ipsen S.A., Anhui Anke Biotechnology (Group) Co.,
Ltd., Novartis AG, Novo Nordisk A/S, Eli Lilly and Company, Merck
KGaA, and Pfizer Inc.
The significant growth is expected in the global human growth hormone
market, according to the market research report by Transparency
Market Research (TMR). The market is likely to register CAGR of 6.2%
during the forecast period 2017-2026. The global human growth hormone
market is also expected to reach US$ 5,261.5 million revenue by the
end of 2026.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16283
The global market for human growth hormone is segmented into
indication, distribution channel, route of administration, and
region. Based on the route of administration, the market is further
segmented into Oral, Intramuscular, Subcutaneous, and Intravenous.
Among these, Subcutaneous is expected to witness the highest growth
in the market during 2017-2026.
By distribution channel, the market segment includes clinics, online
pharmacy, retail pharmacy, and hospital pharmacy. Hospital pharmacy
is anticipated to witness strong growth throughout the forecast
period.
Based on the indication, the market is further segmented into
prader-willi syndrome, idiopathic short stature, turner syndrome,
growth hormone deficiency, and other indications. Growth hormone
deficiency is expected to be the largest segment in the global human
growth hormone market.
North America is expected to be the dominating region in the global
human growth hormone market. The growth in North America is
attributed to the affordability of costly medicines and local
presence of leading companies. Moreover, the availability of various
human growth hormone drugs in the U.S. for treatment of growth
hormone deficiency is also driving the market growth in the region.
Ongoing research and development in the human growth hormone market
and increasing investment by companies is also contributing to the
growth of the market in North America.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment